Pfizer's Covid Boost Crashes to Earth - WSJ
Pfizer, the EU, and disappearing ink – POLITICO
Pfizer CEO sold US$5.6M in stock the day he announced promising vaccine news | CTV News
Lucky Pfizer CEO Bourla cashes out $5.6M worth of stock—perfectly legally—as COVID-19 vaccine data lift market | Fierce Pharma
Pfizer CEO reveals growth plan as company faces up to $18 billion revenue hit
Pfizer CEO tests positive for COVID for a second time | Reuters
Pfizer CEO sold $5.6 million worth of stock amid the pandemic
Pfizer CEO Joins Host of Executives at Covid-19 Vaccine Makers in Big Stock Sale - WSJ
Pfizer's CEO sold $5.6 million in stock the day he announced promising vaccine news | CNN Business
Pfizer CEO Defends His Drug Firm's Shares
Pfizer's answer to tumbling stock is focusing on crowded cancer drug market | The Seattle Times
Pfizer CEO Albert Bourla received $24.3 million in total compensation for 2021
Pfizer CEO Joins Host of Executives at Covid-19 Vaccine Makers in Big Stock Sale - WSJ
Pfizer's CEO sold $5.6 million in stock the day he announced promising vaccine news | CNN Business
Pfizer CEO sold $5.6 million worth of stock amid the pandemic - YouTube
Pfizer CEO Albert Bourla sold US$5.6 million stock on day of vaccine news
Breaking down Pfizer's CEO stock sale: Securities lawyer - YouTube
Pfizer Pulls Experimental Twice-Daily Weight Loss Drug—Shares Slide 6% To Multiyear Low
Pfizer CEO Read to Step Aside at Year's End - WSJ
Pfizer CEO: 2023 will be a 'pivotal year' as COVID-19 drug sales wane
Pfizer's stock heads for biggest drop in 15 years as guidance falls short of estimates - MarketWatch
Pfizer CEO sold $5.6-million of stock on day of COVID-19 vaccine update - The Globe and Mail
Pfizer CEO, CFO Sell $13 Million in Stock - Barron's
Pfizer Stock Is Falling. Did Investors Misunderstand the Revenue Guidance? - Barron's
Federal Lawmakers Invest Big in COVID-19 Vaccine, Treatment Companies
